Condition
Major Adverse Cardiovascular Events clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Major Adverse Cardiovascular Events clinical trials that are recruiting, at sites in 3 countries (most in China (2), France (1), Egypt (1)). 1 was first registered in the last 30 days. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 3Countries
Newest Major Adverse Cardiovascular Events clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement? | — | Sohag | Recruiting | Oct 22, 2026 |
| Plasma multi-omics prediction of left ventricular remodeling and major cardiac events after STEMI | — | Beijing, Beijing Municipality | Recruiting | Mar 20, 2025 |
| Assessing the Systolic Rise Time's ability to predict limb and cardiovascular events in severe peripheral artery disease | — | Amiens | Recruiting | Mar 19, 2024 |
| Using CCTA to improve management of stable chest pain | — | Beijing, Beijing Municipality and 3 other locations | Recruiting | Dec 31, 2020 |
All recruiting trials (4)
-
Is geographic mismatch linked to short-term major heart problems after long drug-eluting stent placement?
This study checks whether geographic mismatch can predict short-term major adverse cardiovascular events after a long drug-eluting stent is placed in the coronary arteries.
-
Plasma multi-omics prediction of left ventricular remodeling and major cardiac events after STEMI
This research tests whether blood multi-omics (proteins, metabolites, lipids, transcripts and immune markers) can predict left ventricular adverse remodeling (LVAR) and major adverse cardiovascular events (MACE) in adults after a first STEMI treated with primary PCI.
-
Assessing the Systolic Rise Time's ability to predict limb and cardiovascular events in severe peripheral artery disease
This study is testing if a specific measurement from the foot can help predict serious problems with limbs and heart health in people with severe peripheral artery disease.
-
Using CCTA to improve management of stable chest pain
This study is testing if using a special heart scan called CCTA can help doctors better manage stable chest pain and reduce serious heart problems for patients suspected of having blocked arteries.
Related topics
Quick answers
How many Major Adverse Cardiovascular Events clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), France (1 trial), Egypt (1 trial). Each study page lists its sites and which ones are recruiting.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.